Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Tenaya Therapeutics, Inc. (TNYA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Tenaya Therapeutics, Inc. (TNYA), most recent 12 months reported: net loss $103.11M, free cash flow -$52.59M. Latest balance sheet on file: liquid cash $78.08M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): SCHOLAR ROCK HOLDING CORPORATION · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC. · Instil Bio, Inc. · Tevogen Inc. · Viskase Holdings, Inc. · Vor Biopharma Inc. · Zura Bio Ltd

Stock screener

Watchlist